Tag: Advanced Acclerator Applications
Peptide Receptor Radionuclide Therapy, PRRT: Updates and Locations
July 26, 2018
Since we shared the news of the FDA’s January 26, 2018 approval of peptide receptor radionuclide therapy, PRRT, with Lutathera (lutetium Lu 177 dotatate), more information has become available for the neuroendocrine tumor community, including updates…
READ MORE
